BIOMAT Database Logo BIOMAT Database Logo

Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection. 1991

D Portetelle, and K Limbach, and A Burny, and M Mammerickx, and P Desmettre, and M Riviere, and J Zavada, and E Paoletti
Faculty of Agronomy, Gembloux, Belgium.

The bovine leukaemia virus (BLV) envelope gene encoding extracellular glycoprotein gp51 and transmembrane glycoprotein gp30 was cloned into the HA locus of vaccinia virus (Copenhagen strain), downstream of the vaccinia virus early-late promoter, H6, or a triple promoter element consisting of the promoter for the vaccinia virus H6 gene, the promoter for the cowpox virus A-type inclusion (ATI) gene and the promoter for the vaccinia virus HA gene. Inoculation of rabbits or sheep with the recombinant vaccinia virus coding for gp51 and gp30 or an uncleaved env precursor induced neutralizing antibodies to BLV. These antibodies competed with monoclonal antibodies directed against gp51 epitopes F, G, and H previously shown to be of crucial importance for BLV infection. Seven out of eight sheep vaccinated with the vaccinia recombinants resisted a drastic challenge (1.5 x 10(3) sheep infectious doses) with BLV-infected lymphocytes. These results show that vaccination with BLV env vaccinia recombinants protects sheep against infection with extremely high doses of BLV-infected heterologous lymphocytes.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D001909 Leukemia Virus, Bovine The type species of DELTARETROVIRUS that causes a form of bovine lymphosarcoma (ENZOOTIC BOVINE LEUKOSIS) or persistent lymphocytosis. BLV,Bovine Leukemia Virus,Cattle Leukemia Virus,Leukemia Virus, Cattle,Virus, Bovine Leukemia,Virus, Cattle Leukemia
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004274 DNA, Recombinant Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected. Genes, Spliced,Recombinant DNA,Spliced Gene,Recombinant DNA Research,Recombination Joint,DNA Research, Recombinant,Gene, Spliced,Joint, Recombination,Research, Recombinant DNA,Spliced Genes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012756 Sheep Any of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS. Ovis,Sheep, Dall,Dall Sheep,Ovis dalli

Related Publications

D Portetelle, and K Limbach, and A Burny, and M Mammerickx, and P Desmettre, and M Riviere, and J Zavada, and E Paoletti
Expression of bovine leukaemia virus envelope gene by recombinant vaccinia viruses.
October 1990, Virus research,
D Portetelle, and K Limbach, and A Burny, and M Mammerickx, and P Desmettre, and M Riviere, and J Zavada, and E Paoletti
Immunogenicity of a recombinant vaccinia virus expressing envelope a glycoprotein of bovine leukaemia virus.
October 1988, Vaccine,
D Portetelle, and K Limbach, and A Burny, and M Mammerickx, and P Desmettre, and M Riviere, and J Zavada, and E Paoletti
Protective effects against simian immunodeficiency virus agm (SIVagm) infection in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the SIVagm envelope gene.
October 1999, Vaccine,
D Portetelle, and K Limbach, and A Burny, and M Mammerickx, and P Desmettre, and M Riviere, and J Zavada, and E Paoletti
Expression of AIDS virus envelope gene in recombinant vaccinia viruses.
January 1986, Nature,
D Portetelle, and K Limbach, and A Burny, and M Mammerickx, and P Desmettre, and M Riviere, and J Zavada, and E Paoletti
Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.
October 1989, Journal of virology,
D Portetelle, and K Limbach, and A Burny, and M Mammerickx, and P Desmettre, and M Riviere, and J Zavada, and E Paoletti
Expression of the HTLV-III envelope gene by a recombinant vaccinia virus.
January 1986, Nature,
D Portetelle, and K Limbach, and A Burny, and M Mammerickx, and P Desmettre, and M Riviere, and J Zavada, and E Paoletti
The possibility of specific protection against bovine leukaemia virus infection and bovine leukaemia with inactivated BLV.
January 1983, The British veterinary journal,
D Portetelle, and K Limbach, and A Burny, and M Mammerickx, and P Desmettre, and M Riviere, and J Zavada, and E Paoletti
Long-term protection against bovine leukaemia virus replication in cattle and sheep.
April 2000, The Journal of general virology,
D Portetelle, and K Limbach, and A Burny, and M Mammerickx, and P Desmettre, and M Riviere, and J Zavada, and E Paoletti
Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
April 1993, Journal of virology,
D Portetelle, and K Limbach, and A Burny, and M Mammerickx, and P Desmettre, and M Riviere, and J Zavada, and E Paoletti
Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene.
January 1997, The Journal of general virology,
Copied contents to your clipboard!